Dynamic Technology Lab’s MaxCyte MXCT Stock Holding History

Dynamic Technology Lab’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,222	Closed	-$40K	–	1075
2025 Q2	$40K	Buy	+18,222	New	+$44.1K	0.01%	877

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

AIM

AXA Investment Managers Puteaux, France $37.1B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's MXCT Position: Q3 2025 in Review

Dynamic Technology Lab sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 18,222 shares — an estimated $40K sold.

Dynamic Technology Lab first reported a position in MXCT in Q2 2025 and held it in 1 quarter. The position peaked at $40K in Q2 2025. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

Dynamic Technology Lab reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
Dynamic Technology Lab sold 18,222 MaxCyte shares in Q3 2025, an estimated $40K.
Dynamic Technology Lab first reported a position in MaxCyte in Q2 2025 and held it in 1 quarter.
Dynamic Technology Lab's MaxCyte position peaked at $40K in Q2 2025.
112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.